De Bernardi di Valserra M - Search Results

1

Chronic toxicity study on a new glucan extracted from Candida albicans in rats.

Feletti F, De Bernardi di Valserra M, Contos S, Mattaboni P, Germogli R. Feletti F, et al. Among authors: de bernardi di valserra m. Arzneimittelforschung. 1992 Nov;42(11):1363-7. Arzneimittelforschung. 1992. PMID: 1492853

2

Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers.

de Bernardi di Valserra M, Germogli R, Feletti F, Covini D, Borgonovo E. de Bernardi di Valserra M, et al. Arzneimittelforschung. 1992 May;42(5):632-6. Arzneimittelforschung. 1992. PMID: 1530676

3

Chronic toxicity of taurohyodeoxycholic acid in rats.

De Bernardi di Valserra M, Tripodi AS, Contos S, Mattaboni P, Germogli R. De Bernardi di Valserra M, et al. Arzneimittelforschung. 1993 Aug;43(8):880-7. Arzneimittelforschung. 1993. PMID: 8216447

4

Chronic toxicity of taurohyodeoxycholic acid in dogs.

Feletti F, Tripodi AS, De Bernardi di Valserra M, Germogli R. Feletti F, et al. Among authors: de bernardi di valserra m. Arzneimittelforschung. 1993 Aug;43(8):888-93. Arzneimittelforschung. 1993. PMID: 8216448

5

Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac.

De Bernardi di Valserra M, Feletti F, Tripodi AS, Contos S, Carabelli A, Maggi L, Germogli R. De Bernardi di Valserra M, et al. Arzneimittelforschung. 1993 Mar;43(3):373-7. Arzneimittelforschung. 1993. PMID: 8489569 Clinical Trial.

6

Lack of effect of a single-dose of sulglicotide on the bioavailability of diclofenac.

De Bernardi di Valserra M, Feletti F, Bertè F, Nazzari M, Cenedese A, Cornelli U. De Bernardi di Valserra M, et al. Eur J Clin Pharmacol. 1988;34(2):211-2. doi: 10.1007/BF00614561. Eur J Clin Pharmacol. 1988. PMID: 3383993

7

In vitro/in vivo correlation of prolonged release dosage forms containing diltiazem HCI.

Caramella C, Ferrari F, Bonferoni MC, Sangalli ME, De Bernardi di Valserra M, Feletti F, Galmozzi MR. Caramella C, et al. Among authors: de bernardi di valserra m. Biopharm Drug Dispos. 1993 Mar;14(2):143-60. doi: 10.1002/bdd.2510140206. Biopharm Drug Dispos. 1993. PMID: 8453024

8

Bioavailability of suckable tablets of oral N-acetylcysteine in man.

De Bernardi di Valserra M, Mautone G, Barindelli E, Lualdi P, Feletti F, Galmozzi MR. De Bernardi di Valserra M, et al. Eur J Clin Pharmacol. 1989;37(4):419-21. doi: 10.1007/BF00558514. Eur J Clin Pharmacol. 1989. PMID: 2598977

9

A computer-aided simulation approach in the development of a prolonged release formulation.

Rossi S, Ferrari F, Bonferoni MC, Caramella C, La Manna A, De Bernardi Di Valserra M, Feletti F. Rossi S, et al. Among authors: de bernardi di valserra m. Boll Chim Farm. 1991 Dec;130(11):443-8. Boll Chim Farm. 1991. PMID: 1809298

10

Swelling-restricted minimatrices for controlled release of drugs. Preliminary in-vivo studies.

Caramella C, Ferrari F, Bonferoni MC, Gazzaniga A, Sangalli ME, Conte U, De Bernardi di Valserra M, Feletti F. Caramella C, et al. Among authors: de bernardi di valserra m. Boll Chim Farm. 1989 Oct;128(10):310-4. Boll Chim Farm. 1989. PMID: 2635916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters